 Partnership
October 20, 2025
SAN JOSE, Calif., Oct. 17, 2025 Rani Therapeutics Holdings, Inc. (Nasdaq: RANI), a pioneering clinical-stage biotherapeutics company dedicated to the oral delivery of biologics and pharmaceuticals, has officially announced a strategic partnership with Chugai Pharmaceutical Co., Ltd. The collaboration, which is val...
|
Product Service News
October 20, 2025
Breakthrough in Smoking Cessation: Achieve Life Sciences Secures FDA s National Priority Voucher Seattle, WA - October 2023 - In a landmark development, Achieve Life Sciences has been granted the FDA Commissioner s National Priority Voucher for cytisinicline, highlighting it as a pioneering treatment for nicotine ...
|
Product Service News
October 20, 2025
The Semiconductor Revolution: How AI as a Service, Durable Connectivity, and Industry Crossovers Shape the Future In today’s rapidly evolving technological landscape, the integration of advanced solutions across sectors is pivotal to staying competitive. Recent developments ranging from advancements in AI technolo...
|
|
 Product Service News
October 20, 2025
In an era where accessibility to homeownership remains a critical issue for many American families, TransUnion has rolled out an innovative suite of mortgage credit offerings designed to reshape the landscape of credit scoring. These new solutions not only provide lenders with expanded choice and certainty but also ...
 Product Service News
October 20, 2025
Tonix Pharmaceuticals Showcases Promising Data for TNX-801 Mpox Vaccine at the World Vaccine Congress Europe 2025In a significant stride towards combating mpox (formerly known as monkeypox) and smallpox, Tonix Pharmaceuticals announced their presentation of pivotal data on TNX-801, a live virus vaccine investigatio...
|
|
Our most Popular Articles
|
Clinical Study
May 23, 2025
At the 2025 ASCO Annual Meeting, Biodesix announced significant discoveries from their INSIGHT study, emphasizing the predictive capabilities of the VeriStrat Host Immune Classifier (HIC) in assessing overall survival outcomes for patients with non-small cell lung cancer (NSCLC) treated with immunotherapies. This ar...
|
Clinical Study
June 20, 2025
Abstract: NKGen Biotech is at the forefront of developing innovative cellular therapies, including Troculeucel, which shows promise in treating post-stroke and Alzheimer’s disease (AD) patients. Recent advancements include the administration of Troculeucel to a stroke patient under an FDA-cleared compassionate use...
|
Announcement
September 12, 2025
In a significant step towards boosting its growth and innovation capabilities, Wearable Devices Ltd. (Nasdaq: WLDS, WLDSW) has announced a two-pronged approach to secure funding, alongside notable advancements in its product offerings. As the firm continues to carve out a niche in the competitive market of artificia...
|
|
|
Company News
|
Product Service News
October 20, 2025
Breakthrough in Smoking Cessation: Achieve Life Sciences Secures FDA s National Priority Voucher Seattle, WA - October 2023 - In a landmark development, Achieve Life Sciences has been granted the FDA Commissioner s National Priority Voucher for cytisinicline, highlighting it as a pioneering treatment for nicotine ...
|
Product Service News
October 20, 2025
The Semiconductor Revolution: How AI as a Service, Durable Connectivity, and Industry Crossovers Shape the Future In today’s rapidly evolving technological landscape, the integration of advanced solutions across sectors is pivotal to staying competitive. Recent developments ranging from advancements in AI technolo...
|
Partnership
October 20, 2025
In a groundbreaking partnership, Datavault AI (NASDAQ: DVLT) has announced a collaboration with Max International AG to launch a digital exchange in Switzerland focused on tokenizing real-world assets (RWAs). This venture aims to tackle significant barriers in institutional tokenization, a sector identified as holdi...
|
|
|
Company News
 Product Service News
October 20, 2025
|
Company News
 Product Service News
October 20, 2025
|
Company News
 Product Service News
October 20, 2025
|
More Company News
|
Clinical Study
October 20, 2025
|
Product Service News
October 20, 2025
|
Product Service News
October 20, 2025
|
Product Service News
October 20, 2025
|
Clinical Study
October 20, 2025
|
Clinical Study
October 20, 2025
|
Clinical Study
October 20, 2025
|
Announcement
October 20, 2025
|
Clinical Study
October 20, 2025
|
Announcement
October 20, 2025
|
|
|
|
Related News
|
Product Service News
|
Product Service News
|
|
Stocks
|
Business Update
|
Business Update
|
|
Clinical Study
|
|
|
|
Business News
|
 Product Service News
In an era where accessibility to homeownership remains a critical issue for many American families, TransUnion has rolled out an innovative suite of mortgage credit offerings designed to reshape the landscape of credit scoring. These new solutions not only provide lenders with expanded choice and certainty but also ...
|
|
Product Service News
Tonix Pharmaceuticals Showcases Promising Data for TNX-801 Mpox Vaccine at the World Vaccine Congress Europe 2025In a significant stride towards combating mpox (formerly known as monkeypox) and smallpox, Tonix Pharmaceuticals announced their presentation of pivotal data on TNX-801, a live virus vaccine investigatio...
|
 Clinical Study
Navigating Breakthroughs: Climb Bio s Strategic Advances in IgA Nephropathy Treatment Climb Bio Inc. is poised to make an impressive mark at the forthcoming American Society of Nephrology (ASN) Kidney Week 2025. The company is set to present promising preclinical data concerning CLYM116, an innovative anti-APRIL mon...
|
 Product Service News
Sight Sciences Announces Medicare Fee Schedule for TearCare Procedure, Enhancing Access to Interventional Dry Eye Treatment MENLO PARK, Calif., Oct. 17, 2025 Sight Sciences, Inc. (Nasdaq: SGHT), a pioneering eyecare technology company dedicated to revolutionizing the treatment landscape for eye-related conditio...
|
 Partnership
SAN JOSE, Calif., Oct. 17, 2025 Rani Therapeutics Holdings, Inc. (Nasdaq: RANI), a pioneering clinical-stage biotherapeutics company dedicated to the oral delivery of biologics and pharmaceuticals, has officially announced a strategic partnership with Chugai Pharmaceutical Co., Ltd. The collaboration, which is val...
|
Our Most Popular Articles
|
 Clinical Study
At the 2025 ASCO Annual Meeting, Biodesix announced significant discoveries from their INSIGHT study, emphasizing the predictive capabilities of the VeriStrat Host Immune Classifier (HIC) in assessing overall survival outcomes for patients with non-small cell lung cancer (NSCLC) treated with immunotherapies. This ar...
|
|
Clinical Study
Abstract: NKGen Biotech is at the forefront of developing innovative cellular therapies, including Troculeucel, which shows promise in treating post-stroke and Alzheimer’s disease (AD) patients. Recent advancements include the administration of Troculeucel to a stroke patient under an FDA-cleared compassionate use...
|
 Announcement
In a significant step towards boosting its growth and innovation capabilities, Wearable Devices Ltd. (Nasdaq: WLDS, WLDSW) has announced a two-pronged approach to secure funding, alongside notable advancements in its product offerings. As the firm continues to carve out a niche in the competitive market of artificia...
|
More News
|
 Product Service News
Breakthrough in Smoking Cessation: Achieve Life Sciences Secures FDA s National Priority Voucher Seattle, WA - October 2023 - In a landmark development, Achieve Life Sciences has been granted the FDA Commissioner s National Priority Voucher for cytisinicline, highlighting it as a pioneering treatment for nicotine ...
|
 Product Service News
The Semiconductor Revolution: How AI as a Service, Durable Connectivity, and Industry Crossovers Shape the Future In today’s rapidly evolving technological landscape, the integration of advanced solutions across sectors is pivotal to staying competitive. Recent developments ranging from advancements in AI technolo...
|
 Partnership
In a groundbreaking partnership, Datavault AI (NASDAQ: DVLT) has announced a collaboration with Max International AG to launch a digital exchange in Switzerland focused on tokenizing real-world assets (RWAs). This venture aims to tackle significant barriers in institutional tokenization, a sector identified as holdi...
|
 Product Service News
WeightWatchers Partners with Amazon Pharmacy for Enhanced Medication Accessibility Expanding Health Solutions Through CollaborationIn a strategic move aimed at enhancing the convenience and affordability of medication for its members, WW International, Inc. (NASDAQ: WW), widely known as WeightWatchers, has announc...
|
 Product Service News
: The European Medicines Agency’s Committee for Medicinal Products for Human Use (CHMP) has issued positive opinions recommending approval for Libtayo (cemiplimab) in the adjuvant treatment of patients with cutaneous squamous cell carcinoma (CSCC) at high risk of recurrence, as well as for Dupixent (dupilumab) in...
|
|
Product Service News
Wrap Technologies, a firm focused on developing non-lethal solutions for law enforcement and security applications, is pushing the boundaries of drone technologies with its latest offerings. The company has recently announced the launch of its next-generation drone responder product, the DFR-X. Designed to transitio...
|
 Clinical Study
In a significant advancement for breast cancer treatment, the latest findings from the VERITAC-2 clinical trial have revealed that vepdegestrant, a promising therapeutic agent, offers notable benefits for patients grappling with ESR1-mutated, ER+/HER2- advanced or metastatic breast cancer. Notably, these patients ha...
|
 Product Service News
In the ever-evolving landscape of mining investments, Caledonia Mining Corporation Plc has recently found itself at a pivotal crossroads marked by changes in its shareholder dynamics and production strategies. The latest developments regarding Caledonia, a gold producer operating primarily in Zimbabwe, highlight bot...
|
 Product Service News
In the ever-evolving landscape of financial investments, the Sprott Uranium Miners ETF (URNM) recently announced amendments to the North Shore Global Uranium Mining Index methodology, an insightful shift aimed at enhancing both liquidity and the effectiveness of ETF tracking. Such changes signal not merely an adjust...
|
 Product Service News
In a significant strategic maneuvre, Lollicup USA Inc., a subsidiary of Karat Packaging Inc. (Nasdaq: KRT), has formally announced its relocation of headquarters from Chino, California, to Rockwall, Texas, effective October 17, 2025. This decision aligns with a growing trend of businesses seeking favorable economic ...
|
 Clinical Study
: The treatment landscape for cancer, specifically resistant tumors, has taken a transformative turn with the advent of novel therapeutic agents. This article analyzes the promising results from Sensei Biotherapeutics, Inc. s recent clinical data presented at the ESMO Congress 2025, highlighting the efficacy of the ...
|
 Clinical Study
Transformative Advances in IgA Nephropathy: Vor Bio s Promising Phase 3 Clinical Data Presentation at ASN Kidney Week 2025 In a groundbreaking development that is set to captivate the nephrology community, Vor Bio, a prominent clinical-stage biotechnology entity specializing in the treatment of autoimmune diseases, ...
|
 Clinical Study
Kiniksa Pharmaceuticals Receives U.S. FDA Orphan Drug Designation for KPL-387 in Pericarditis Treatment LONDON, Oct. 17, 2025 Kiniksa Pharmaceuticals International, plc (Nasdaq: KNSA), a biopharmaceutical company focused on developing and commercializing novel therapies for diseases with unmet needs, particularly in the cardiovascular space, has announced that the U.S. Food and Drug Administration (FDA) has granted Orphan Drug Designation to KPL-387. This designation pertains to the treatment of pericarditis, including its recurrent form.KPL-387 is an independently developed monoclonal antibody that targets the human interleukin-1 receptor 1 (IL-1R1). By inhibiting the signaling activity of the cytokines interleukin-1 (IL-1), the medication offers a new approach in managing pericarditis, a condition characterized by inflammation of the pericardium, which can lead to frequent recurrences, pain, and potentially severe complications if not effectively managed.
|
 Announcement
In a significant step towards embracing the post-quantum era, SEALSQ Corp (NASDAQ: LAES) has announced the development of QASIC, a quantum-resistant ASIC, in collaboration with ICAlps. This strategic move aims to provide a unified offering, encompassing Catalog ICs, Custom ICs, and Security IP, all tailored to meet ...
|
 Clinical Study
: This article discusses recent advancements in treatment options for thalassemia, with a focus on the positive progress made with PYRUKYND (mitapivat). Agios Pharmaceuticals has reported significant milestones, including a positive opinion from the Committee for Medicinal Products for Human Use (CHMP) and the FDA...
|
 Announcement
Revolutionizing Cancer Treatment: Evaxion s AI-designed Vaccine Achieves Breakthrough Results In a remarkable stride for cancer treatment, Evaxion A/S, a clinical-stage TechBio leader, has announced unprecedented efficacy data from its personalized cancer vaccine, EVX-01, in a Phase 2 trial targeting advanced melano...
|
|
|
|
|
